STOCK TITAN

Modular Medical (MODD) Financials

MODD NASDAQ
Trailing 12 months to September 30, 2026
Net Income -$27.3M n/m YoY
EPS (Diluted) -$12.36 FY2026 annual
Free Cash Flow -$28.2M n/m YoY
Operating Cash Flow -$25.2M n/m YoY
Market Cap $18.1M as of Nov 16, 2026
Price / Sales n/m no full year of revenue reported yet
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to September 30, 2026
Price / Book 1.6x on $11.4M equity, Q2 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 16, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2027, ended Sep 30, 2026 Reported Currency USD FYE March

Newest figures come from the 10-Q for Q2 FY2027, filed Nov 16, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MODD SEC filings page.

This page shows Modular Medical, Inc. (MODD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MODD FY2026

The development-stage business is increasing R&D and capital spending while financing inflows fund ongoing cash needs.

FY2026’s net loss was $28.2M while operating cash flow was -$23.8M, showing little conversion cushion between accounting loss and cash loss. Free cash flow reached -$27.7M after $3.9M of investing outflow, so reinvestment added to cash consumption rather than obscuring it.

R&D rose 35.9% in FY2026 and SG&A rose 74.4%, indicating broader spending expansion rather than a single cost line driving the decline. Net loss widened to $28.2M, so the higher investment has not yet produced operating self-funding in the reported period.

Financing cash inflow was $21.5M against operating cash flow of -$23.8M, meaning external funding supplied nearly the amount absorbed by operations. The current ratio fell from 10.7x in FY2025 to 4.0x in FY2026, reflecting a materially tighter short-term balance-sheet position.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for Modular Medical, Inc., because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.

Piotroski F-Score Partial
1/6

Modular Medical, Inc. passes 1 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality No Cash Backing
N/A

Modular Medical, Inc. reported a net loss of $28.2M while operations used $23.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

EBITDA
-$6.7M
YoYn/m
QoQn/m

Modular Medical, Inc.'s EBITDA was -$6.7M in Q2 2027, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income
-$7.1M
YoYn/m
QoQn/m

Modular Medical, Inc. reported a net loss of $7.1M in Q2 2027. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
-$0.90
QoQn/m

Modular Medical, Inc. earned -$0.90 per diluted share (EPS) in Q2 2027. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Revenue

Not reported for Q2 2027.

Cash & Balance Sheet

Free Cash Flow
-$6.4M
YoYn/m
QoQn/m
5Y CAGRn/m

Modular Medical, Inc. recorded an outflow of $6.4M in free cash flow in Q2 2027, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt
$5.1M
YoY-4.1%
QoQ+30.1%
5Y CAGR+44.9%
10Y CAGR+39.1%

Modular Medical, Inc. held $5.1M in cash as of Q2 2027; no long-term debt figure is on record for that period.

Shares Outstanding
10M
QoQ+19.5%

Modular Medical, Inc. had 10M shares outstanding in Q2 2027. Against the prior quarter it is up 19.5%.

Dividends Per Share

Not reported for Q2 2027.

Margins & Returns

Return on Equity
-62.2%
YoY+26.6pp
QoQ-1.9pp

Modular Medical, Inc.'s quarterly ROE was -62.2% in Q2 2027: one quarter's net income over shareholder equity, not annualized. This is up 26.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.9 percentage points.

Gross Margin

Not reported for Q2 2027.

Operating Margin

Not reported for Q2 2027.

Net Margin

Not reported for Q2 2027.

Capital Allocation

R&D Spending
$3.9M
YoY-29.8%
QoQ-10.2%

Modular Medical, Inc. invested $3.9M in research and development in Q2 2027. This represents a decrease of 29.8% from the same quarter a year earlier. Against the prior quarter it is down 10.2%.

Capital Expenditures
$88K
YoY-88.6%
QoQ-87.2%
5Y CAGR+100.7%

Modular Medical, Inc. invested $88K in capex in Q2 2027, funding long-term assets and infrastructure. This represents a decrease of 88.6% from the same quarter a year earlier. Against the prior quarter it is down 87.2%.

Share Buybacks

Not reported for Q2 2027.

MODD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MODD quarterly income statement
MetricQ2'2710-QQ1'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
R&D Expenses$3.9M-29.8%$4.4M-14.9%$3.8M-2.4%$5.4M+40.3%$5.6M+51.1%$5.1M+60.2%$3.9M+26.4%$3.9M+0.4%
SG&A Expenses$3.2M+43.8%$2.2M+29.8%$1.8M+76.9%$1.8M+83.7%$2.2M+72.8%$1.7M+64.5%$1.0M-13.5%$1.0M-30.0%
Operating Income-$7.1Mn/m-$6.5Mn/m-$5.7Mn/m-$7.2Mn/m-$7.8Mn/m-$6.8Mn/m-$5.0Mn/m-$4.9Mn/m
EBITDA-$6.7Mn/m-$6.0Mn/m-$5.2Mn/m-$6.8Mn/m-$7.4Mn/m-$6.4Mn/m-$4.7Mn/m-$4.6Mn/m
Income Tax$2K0.0%N/AN/AN/A$2K0.0%N/AN/AN/A
Net Income-$7.1Mn/m-$6.5Mn/m-$6.4Mn/m-$7.4Mn/m-$7.8Mn/m-$6.7Mn/m-$4.9Mn/m-$4.8Mn/m
EPS (Basic)-$0.90-$1.19N/A-$3.30-$4.21-$3.70-$3.60n/m-$3.90
EPS (Diluted)-$0.90-$1.19N/A-$3.30-$4.21-$3.70-$3.60n/m-$3.90
Diluted Shares (Avg)8M5MN/A2M2M2MN/A1M

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Interest Expense.

MODD Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MODD quarterly balance sheet
MetricQ2'2710-QQ1'2710-QQ4'2610-KQ3'2610-QQ2'26FilingQ1'26FilingQ4'2510-KQ3'2510-Q
Total Assets$12.7M-1.8%$12.3M-13.5%$14.8M-20.8%$10.3M-15.6%$13.0M+47.9%$14.2M+40.7%$18.7M+35.7%$12.1M+96.0%
Current Assets$5.9M-1.4%$4.8M-41.6%$7.5M-44.2%$3.5M-52.7%$5.9M+42.4%$8.3M+53.4%$13.5M+39.4%$7.3M+213.0%
Cash & Equivalents$5.1M-4.1%$3.9M-47.9%$6.9M-47.0%$2.9M-58.0%$5.3M+36.6%$7.5M+48.9%$13.1M+41.8%$7.0M+241.3%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Total Liabilities$1.3M-68.7%$1.5M-36.0%$1.9M+13.0%$4.4M+132.0%$4.2M+126.7%$2.3M+13.2%$1.7M-27.0%$1.9M-19.8%
Current Liabilities$1.3M-67.5%$1.5M-27.4%$1.9M+48.1%$2.2M+57.6%$4.0M+225.1%$2.0M+52.8%$1.3M-13.1%$1.4M-3.9%
Non-Current Liabilities$0-100.0%$0-100.0%$0-100.0%$2.2M+336.3%$161K-73.6%$278K-61.1%$393K-51.9%$504K-44.9%
Total Equity$11.4M+30.2%$10.8M-9.1%$13.0M-24.1%$5.9M-42.7%$8.8M+26.8%$11.8M+47.7%$17.1M+48.0%$10.3M+166.9%
Retained Earnings-$126.6Mn/m-$119.5Mn/m-$113.0Mn/m-$106.6Mn/m-$99.2Mn/m-$91.5Mn/m-$84.8Mn/m-$79.8Mn/m

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

MODD Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MODD quarterly cash flow statement
MetricQ2'2710-QQ1'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Operating Cash Flow-$6.3Mn/m-$6.0Mn/m-$5.8Mn/m-$7.2Mn/m-$5.4Mn/m-$5.4Mn/m-$4.3Mn/m-$4.1Mn/m
Depreciation & Amortization$447K+14.3%$501K+22.2%$441K+35.3%$430K+53.0%$391K+50.4%$410K+109.2%$326K+128.0%$281K+116.2%
Stock-Based CompensationN/A$447K-38.3%N/A$2K-60.0%$4K-55.6%$724K+35.3%N/A$5K-54.5%
Capital Expenditures$88K-88.6%$688K-26.3%$1.0M+6.0%$1.2M+125.5%$771K+378.9%$934K+10.9%$948K+96.3%$542K+8.6%
Free Cash Flow-$6.4Mn/m-$6.7Mn/m-$6.8Mn/m-$8.4Mn/m-$6.2Mn/m-$6.3Mn/m-$5.3Mn/m-$4.6Mn/m
Investing Cash Flow-$88Kn/m-$688Kn/m-$1.0Mn/m-$1.2Mn/m-$771Kn/m-$934Kn/m-$948Kn/m-$542Kn/m
Financing Cash Flow$7.5M+89.8%$3.6M+396.3%$10.8M-4.8%$6.0M-22.4%$4.0M+43.6%$733K+249.0%$11.4M+1.8%$7.7M+4171.3%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

MODD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MODD quarterly financial ratios
MetricQ2'2710-QQ1'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Return on Equity-62.2%+26.6pp-60.3%-3.7pp-49.3%-20.5pp-125.2%-78.3pp-88.8%-17.2pp-56.6%-5.0pp-28.9%+8.3pp-46.8%+90.2pp
Return on Assets-55.8%+4.3pp-52.9%-5.6pp-43.1%-16.8pp-71.7%-32.2pp-60.0%-3.5pp-47.3%-6.2pp-26.3%+4.7pp-39.5%+45.5pp
Current Ratio4.46+3.0x3.25-0.8x4.03-6.7x1.59-3.7x1.47-1.9x4.040.0x10.69+4.0x5.30+3.7x
Liabilities-to-Equity0.12-0.4x0.14-0.1x0.140.0x0.74+0.6x0.48+0.2x0.20-0.1x0.10-0.1x0.18-0.4x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Debt-to-Equity, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Modular Medical, Inc. MODD FY2026 N/A -$28.2M N/A $18.1M —
Picard Medical, Inc. PMI FY2025 N/A -$27.0M N/A $17.8M —
CVRx, Inc. CVRX FY2025 $56.7M -$53.3M -94.1% $17.5M 53/100
SANUWAVE Health, Inc. SNWV FY2025 $44.1M $11.8M 26.8% $15.6M 59/100
Cytosorbents Corp. CTSO FY2025 $37.1M -$8.2M -22.1% $15.3M 47/100
Nano-X Imaging Ltd NNOX FY2025 $13.0M -$75.0M N/A $25.4M 56/100

Frequently Asked Questions

No, Modular Medical, Inc. (MODD) reported a net loss of $27.3M over the trailing 12 months to September 30, 2026. In fiscal year 2026 it reported a net loss of $28.2M.

Modular Medical, Inc. (MODD) reported diluted earnings per share of -$12.36 for fiscal year 2026. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Modular Medical, Inc. (MODD) had EBITDA of -$25.9M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

Modular Medical, Inc. (MODD) has a return on equity of -217.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

Modular Medical, Inc. (MODD) recorded an outflow of $27.7M in free cash flow during fiscal year 2026. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Modular Medical, Inc. (MODD) recorded an outflow of $23.8M in operating cash flow during fiscal year 2026, representing cash used by core business activities.

Modular Medical, Inc. (MODD) had $14.8M in total assets as of fiscal year 2026, including both current and long-term assets.

Modular Medical, Inc. (MODD) invested $3.9M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Modular Medical, Inc. (MODD) invested $20.0M in research and development during fiscal year 2026.

Modular Medical, Inc. (MODD) had 5.41B shares outstanding as of fiscal year 2026.

Modular Medical, Inc. (MODD) had a current ratio of 4.03 as of fiscal year 2026, which is generally considered healthy.

Modular Medical, Inc. (MODD) had a liabilities-to-equity ratio of 0.14 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2026, because the filing data we hold for that year carries no long-term debt figure.

Modular Medical, Inc. (MODD) had a return on assets of -190.4% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Modular Medical, Inc. (MODD) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $18.1M as of Nov 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Modular Medical, Inc. (MODD) has no price-to-sales ratio at the moment: no full year of revenue reported yet. The market capitalization is $18.1M as of Nov 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2026, Modular Medical, Inc. (MODD) held $6.9M in cash, cash equivalents and investments, and reported an operating cash outflow of $23.8M over that year. Dividing the one by the other, the reported balance equals about 4 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Modular Medical, Inc. (MODD) has a Piotroski F-Score of 1 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Modular Medical, Inc. (MODD) reported a net loss of $28.2M while operations used $23.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top